Compare Alcon AG (ALC) vs ConocoPhillips (COP) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs ConocoPhillips — how do they compare? Alcon AG trades at $66.77 (market cap $32.69B), while ConocoPhillips trades at $109.72 (market cap $132.11B). The key difference: ConocoPhillips is far larger — about 4× Alcon AG's market cap, and ConocoPhillips pays the higher dividend (3.1%). Which is the better fit depends on your goals.
| ALC | COP | |
|---|---|---|
Market Cap | $32.69B | $132.11B |
Sector | Health | Energy |
52-Week High | $92.22 | $133.80 |
52-Week Low | $62.02 | $85.66 |
Enterprise Value | $36.28B | $149.08B |
Dividend Yield | 0.54% | 3.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
ConocoPhillips (COP) trades at $108.44, up 3.54% today, with strong analyst support (74.5% buy ratings) and a $148.86 consensus price target suggesting significant upside. The company maintains solid fundamentals with a 12.58% net margin and 11.25% ROE, though revenue has declined from $78.5B in 2022 to $58.9B in 2025. Technical indicators show bearish momentum despite oversold RSI readings, with key support at $102-103 levels.
COP presents a compelling value opportunity with attractive valuation multiples (P/E 17.56, EV/EBITDA 5.81) and consistent cash flow generation. However, investors face risks from volatile oil prices, declining revenue trends, and geopolitical uncertainties affecting energy markets. The upcoming Q2 earnings report on August 6 will be critical for confirming the bullish analyst outlook.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About ConocoPhillips
ConocoPhillips is a U.S.-based independent exploration and production firm. In 2021, it produced 1.0 million barrels per day of oil and natural gas liquids and 3.2 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2021 were 6.1 billion barrels of oil equivalent.
Read more on COP →
